MDT

98.37

-0.15%↓

VEEV

305.54

+1.74%↑

A

138.56

-2.26%↓

HQY

88.49

+0.61%↑

KALV

10.89

-0.82%↓

MDT

98.37

-0.15%↓

VEEV

305.54

+1.74%↑

A

138.56

-2.26%↓

HQY

88.49

+0.61%↑

KALV

10.89

-0.82%↓

MDT

98.37

-0.15%↓

VEEV

305.54

+1.74%↑

A

138.56

-2.26%↓

HQY

88.49

+0.61%↑

KALV

10.89

-0.82%↓

MDT

98.37

-0.15%↓

VEEV

305.54

+1.74%↑

A

138.56

-2.26%↓

HQY

88.49

+0.61%↑

KALV

10.89

-0.82%↓

MDT

98.37

-0.15%↓

VEEV

305.54

+1.74%↑

A

138.56

-2.26%↓

HQY

88.49

+0.61%↑

KALV

10.89

-0.82%↓

Search

Phreesia Inc

Closed

SectorHealthcare

23.47 -0.84

Overview

Share price change

24h

Current

Min

23.33

Max

23.87

Key metrics

By Trading Economics

Income

4.6M

654K

Sales

1.3M

117M

Profit margin

0.558

Employees

2,082

EBITDA

2.7M

6.8M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+46.08% upside

Dividends

By Dow Jones

Next Earnings

8 Dec 2025

Market Stats

By TradingEconomics

Market Cap

-477M

1.4B

Previous open

24.31

Previous close

23.47

News Sentiment

By Acuity

17%

83%

28 / 371 Healthcare

Technical Score

By Trading Central

Confidence

Neutral Evidence

Phreesia Inc Chart

Past performance is not a reliable indicator of future results.

Related News

7 Oct 2025, 16:58 UTC

Earnings

BMW Trims 2025 View, Citing Weaker Performance in China

7 Oct 2025, 23:43 UTC

Market Talk

Nikkei May Trade Rangebound; Takaichi's Policy Steps in Focus -- Market Talk

7 Oct 2025, 23:36 UTC

Market Talk

Gold Edges Higher, Supported by Possible Hedging Demand -- Market Talk

7 Oct 2025, 23:19 UTC

Market Talk

Veem Can Secure More Defense Deals Following Northrop Grumman Win -- Market Talk

7 Oct 2025, 22:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7 Oct 2025, 22:50 UTC

Market Talk

RBNZ Should Take the Option of a Bigger Cut -- Market Talk

7 Oct 2025, 22:40 UTC

Market Talk

South32's Alaskan Project Seen Starting Sooner, Worth More After U.S. Deal -- Market Talk

7 Oct 2025, 21:56 UTC

Market Talk

Global Equities Roundup: Market Talk

7 Oct 2025, 21:56 UTC

Market Talk

Australia Shares Set to Start Day Roughly Flat -- Market Talk

7 Oct 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7 Oct 2025, 20:44 UTC

Hot Stocks

Stocks to Watch Tuesday Recap: Oracle, Dell, Trilogy Metals -- WSJ

7 Oct 2025, 19:42 UTC

Market Talk

Treasury Yields Fall as Data Blackout Continues -- Market Talk

7 Oct 2025, 19:23 UTC

Acquisitions, Mergers, Takeovers

Private-Equity Stocks Have Gotten Crushed. J.P. Morgan Says This One Is a Buy. -- Barrons.com

7 Oct 2025, 19:07 UTC

Market Talk

Oil Futures Settle Mixed With Higher OPEC+ Supply in View -- Market Talk

7 Oct 2025, 19:02 UTC

Market Talk

U.S. Natural Gas Posts Back-to-Back Gains -- Market Talk

7 Oct 2025, 16:28 UTC

Earnings

BMW to Post Full Quarterly Results, Adjusted Outlook on Nov. 5

7 Oct 2025, 16:28 UTC

Earnings

BMW Remains Committed to Share Buyback Program

7 Oct 2025, 16:27 UTC

Earnings

BMW: Dividend Payout Ratio Remains Between 30% and 40% of Net Income Attributable to Shareholders

7 Oct 2025, 16:27 UTC

Earnings

BMW Sees 2025 FCF in Automotive Segment Above EUR2.5B, Prior Above EUR5B

7 Oct 2025, 16:26 UTC

Earnings

BMW Sees Slight Decline in 2025 Group Earnings Before Tax, Prior Forecast on Same Level as 2024

7 Oct 2025, 16:25 UTC

Earnings

BMW Sees 2025 RoCE in Automotive Segment Between 8% and 10%, Prior 9% to 13%

7 Oct 2025, 16:25 UTC

Earnings

BMW: 2025 Auto EBIT Margin Forecast Range Remains Between 5% to 7%, Lower Part More Likely

7 Oct 2025, 16:23 UTC

Earnings

BMW Decided to Reduce Volume Expectations for Chinese Market in 4Q

7 Oct 2025, 16:22 UTC

Earnings

BMW: Targeted Volume Growth in China Remained Below Expectations

7 Oct 2025, 16:21 UTC

Earnings

BMW Cuts 2025 View

7 Oct 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

7 Oct 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

7 Oct 2025, 16:20 UTC

Market Talk

Home Depot Extended Pro Desk Hours Could Drive Sales Growth -- Market Talk

7 Oct 2025, 16:15 UTC

Market Talk

AMD's OpenAI Deal Resets Competitive Landscape for Chips -- Market Talk

7 Oct 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

Peer Comparison

Price change

Phreesia Inc Forecast

Price Target

By TipRanks

46.08% upside

12 Months Forecast

Average 34.3 USD  46.08%

High 38 USD

Low 31 USD

Based on 12 Wall Street analysts offering 12 month price targets forPhreesia Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

11

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

25.23 / 25.61Support & Resistance

Short Term

Neutral Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

28 / 371 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
help-icon Live chat